Health and Racial Disparities in Diabetes Mellitus Prevalence, Management, Policies, and Outcomes in the United States
- PMID: 39697180
- PMCID: PMC11654833
- DOI: 10.29011/2577-2228.100460
Health and Racial Disparities in Diabetes Mellitus Prevalence, Management, Policies, and Outcomes in the United States
Abstract
Diabetes Mellitus (DM) is a severe and chronic metabolic disorder characterized by hyperglycaemia and various complications, including cardiovascular disease. It is diagnosed when fasting plasma glucose (FPG) level is126 mg/dL (7.0 mmol/L) or higher [1]. Notable differences in DM prevalence are evident among populations in the United States. While DM affects 13% of the general adult population, specific groups, including American Indians/Alaska Natives (14.7%), Hispanics (12.5%), and non-Hispanic Blacks (11.7%), experience disproportionately higher rates. Conversely, lower prevalence rates are observed among non-Hispanic Asians (9.2%) and non-Hispanic Whites (7.5%). Black Americans are twice as likely to succumb to diabetes-related mortality compared to Whites [2]. The overall objective of this review article is to comprehensively address racial disparities in DM within the United States, emphasizing prevalence rates, management strategies, and health outcomes across diverse ethnic groups. To achieve this objective, we conducted a systematic review and meta-analysis utilizing data from nationally representative surveys, healthcare databases, and published literature spanning from 2014 to 2023. Our findings highlight significant racial disparities in DM prevalence, with minority populations, including African Americans, Hispanics, and Native Americans, consistently exhibiting higher rates than their Caucasian counterparts. Beyond prevalence, disparities extend to access to healthcare resources, diabetes education, and preventive measures. Additionally, challenges in DM management, including access to optimal treatment modalities, medication adherence, and diabetes self-management education, are identified among minority populations. Socioeconomic factors, particularly income and education, significantly contribute to these disparities. This review article contributes to the growing body of evidence guiding policymakers, healthcare professionals, and researchers in developing targeted strategies to achieve health equity in diabetes management and prevention. Addressing these disparities is crucial for fostering an inclusive and practical approach to DM care within diverse ethnic populations.
Keywords: Diabetes mellitus; Management; Policies; Prevalence; Racial disparity.
Conflict of interest statement
Conflicts of Interest: The authors declare no conflicts of interest.
Figures



Similar articles
-
State-specific prevalence of selected health behaviors, by race and ethnicity--Behavioral Risk Factor Surveillance System, 1997.MMWR CDC Surveill Summ. 2000 Mar 24;49(2):1-60. MMWR CDC Surveill Summ. 2000. PMID: 10965781
-
Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.MMWR Surveill Summ. 2011 May 20;60(6):1-44. MMWR Surveill Summ. 2011. PMID: 21597458
-
Disparities in Adult Cigarette Smoking - United States, 2002-2005 and 2010-2013.MMWR Morb Mortal Wkly Rep. 2016 Aug 5;65(30):753-8. doi: 10.15585/mmwr.mm6530a1. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27491017
-
The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies.Headache. 2015 Feb;55(2):214-28. doi: 10.1111/head.12506. Epub 2015 Feb 3. Headache. 2015. PMID: 25644596 Review.
-
Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus.Curr Med Res Opin. 2015 May;31(5):913-23. doi: 10.1185/03007995.2015.1029894. Curr Med Res Opin. 2015. PMID: 25772230 Review.
References
-
- Dhaliwal R, Pereira RI, Diaz-Thomas AM, Powe CE, Cardozo LLY, et al. (2022) Eradicating Racism: An Endocrine Society Policy Perspective. J Clin Endocrinol Metab 107: 1205–1215. - PubMed
-
- Shidlovskaya TA, Navalkivska NY (2020) Distortion product otoacoustic emissions among the patients suffering diabetes mellitus type II with hearing impairment. Otorhinolaryngology.
Grants and funding
LinkOut - more resources
Full Text Sources